Breakthrough Eye Implant Marks a New Era in Glaucoma Surgery

Millions of individuals worldwide who suffer from the vision-impairing eye disorder glaucoma will have hope thanks to a revolutionary new discovery in the disease's treatment. The Ciliatech ophthalmology medical technology business has created the first glaucoma implant that doesn't damage the anterior chamber. With the Cilio-scleral Inter-positioning Device (CID), a quick and simple surgical procedure is used without the danger of complications brought on by existing optical implants. The CID appears to have a good chance of ushering in a new age in glaucoma surgery, according to preliminary findings from a 12-month clinical study interim. It functions effectively without producing a filtration bleb, or little blister of fluid on top of the eye's surface or beneath the eyelid. It also carries no threat of other problems.